Serotonin 2C receptor antagonism ameliorates novelty-induced hypophagia in aged mice

Miwa Nahata1, Shuichi Muto, Koji Nakagawa

  • 1Tsumura & Co., Tsumura Research Laboratories, Ibaraki 300-1192, Japan.

Insights

Aged mice show reduced food intake and increased stress when exposed to novel environments. Enhanced serotonin (5-hydroxytryptamine, 5-HT) 2C receptor signaling in the hypothalamus contributes to this novelty-induced hypophagia.

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Aging is associated with altered responses to environmental stimuli.
  • Novelty-induced hypophagia, a decrease in food intake due to new environments, is exacerbated in aged individuals.
  • Serotonin (5-hydroxytryptamine, 5-HT) 2C receptor (5-HT2CR) signaling is implicated in appetite regulation and stress responses.

Purpose of the Study:

  • To investigate the role of 5-HT2CR signaling in novelty-induced hypophagia in aged mice.
  • To compare the effects of novel environments on feeding behavior and stress hormones in young and aged mice.
  • To explore potential therapeutic interventions targeting 5-HT2CR.

Main Methods:

  • Male C57BL/6J mice (young and aged) were exposed to a novel environment.
  • Feeding behavior, corticosterone levels, and hypothalamic gene expression (CRF, CRF1R, POMC) were measured.
  • The effects of 5-HT2CR antagonists (SB242084, rikkunshito) were evaluated.

Main Results:

  • Aged mice exhibited suppressed food intake and elevated corticosterone secretion in novel environments compared to young mice.
  • Hypothalamic CRF and pituitary CRF1R/POMC mRNA expression increased in aged mice exposed to novelty.
  • 5-HT2CR antagonist administration attenuated hypophagia and reduced stress hormone levels in aged mice.
  • 5-HT2CR mRNA expression in the paraventricular nucleus was significantly upregulated in aged mice upon environmental change.

Conclusions:

  • Up-regulated hypothalamic 5-HT2CR function contributes to novelty-induced hypophagia in aged mice.
  • Enhanced 5-HT2CR signaling and subsequent corticotropin-releasing factor (CRF) neuron activation are involved in this phenomenon.
  • 5-HT2CR antagonists represent a potential therapeutic strategy for conditions like depression associated with altered appetite and stress responses.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...